ascopubs.org

Artificial intelligence algorithms for recurrence risk score prediction in early-stage breast cancer: A multicenter study of 437 cases.

This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does not include a full text component.
Frontiers

Artificial Intelligence for Microbial Systems and Biomedical Applications

Advances in artificial intelligence (AI) are transforming the way we analyze, model, and interpret both microbial systems and complex biomedical data.
FierceBiotech

Roche shells out up to $1B for PathAI in move to boost artificial intelligence-powered diagnostics

Roche is set to pay out $750 million upfront to acquire digital pathology specialist Path AI in a move by the pharma giant to accelerate the use of artificial intelligence in diagnostic ...
Forbes

Not All Algorithms Are AI (Part 3): General Intelligence

“Not All Algorithms are AI” is a three-part deep dive into the evolution of algorithms, what brought us to generative AI, and how to understand what this technology will do for your business. In ...

AI-powered electrocardiogram detects early signs of heart failure

Interpreting relatively inexpensive electrocardiograms (ECGs) with an artificial intelligence (AI) algorithm accurately ...

AI/R launches The Algorithm, a new operating model that deepens its role in applying Agentic AI to business

Company consolidates its focus on Agentic AI Engineering, integrating development, agent orchestration, and direct application within client operationsSAN FRANCISCO, May 06, 2026 (GLOBE NEWSWIRE) -- ...